There is a peculiar tension at the heart of Palantir’s current market narrative. The data-analytics specialist just raised its full-year revenue outlook, watched its shares surge by roughly half in a single month, and secured fresh Pentagon momentum — all while its own chief executive systematically trims his personal stake. It is a split-screen picture that leaves investors weighing operational brilliance against the quiet signal of a c-suite cashing out.
The Numbers Tell a Growth Story
The second-quarter results, released on a Saturday, gave bulls plenty of ammunition. Revenue climbed to $1.935 billion, with the US government segment contributing $809 million and US commercial business adding $764 million — a nearly balanced split that underscores the company’s dual-engine model. Management seized the moment to lift its full-year revenue forecast to a range of $8.150 billion to $8.158 billion, while guiding for free cash flow margin of $4.5 billion to $4.7 billion.
The most striking upgrade came from the US commercial segment. Palantir now expects more than $3.424 billion from that business, up from the previously communicated $3.224 billion threshold. That upward revision suggests the civilian side of the US operation is accelerating faster than management anticipated just a few months ago.
The market responded enthusiastically. The stock gained 49 percent over a 30-day stretch, an unusually brisk pace even for a name accustomed to wide swings. At its most recent level of €159.28, the shares trade roughly a quarter above their 50-day moving average of €126.10 — a gap that illustrates just how far short-term momentum has detached from the medium-term baseline. The secondary source puts the price at €160.88 on Friday, with a monthly gain of 51 percent and a relative strength index of 69.1, suggesting the rally has stretched into overbought territory.
Defense Contracts Stack Up
Alongside the earnings story, the defense narrative continues to build. William Blair reaffirmed its “Outperform” rating on August 26, pointing to growing Pentagon orders and a Reuters-reported memo allocating an additional $244 million to Palantir through March 2027. The analyst house also suggested that Maven, the AI-powered targeting system now embedded as a “Program of Record” in the regular defense budget, could surpass $1 billion in annual recurring revenue — a concrete figure rather than speculative hype.
The Pentagon’s fiscal 2027 budget proposal backs that optimism, earmarking $2.30 billion over five years for Maven and the related Joint Fires Network. That Maven had already achieved Program of Record status back in March was well known; what’s new is that the designation is now translating into hard dollar figures.
The pipeline extends beyond Maven. Palantir secured a contract framework worth approximately $876 million with Raytheon for the US Army’s Distributed Common Ground System-Army. The company also pushed back against media reports of a lost $875 million contract with France’s DGSI intelligence agency, pointing to a contract extension finalized in late 2025.
Should investors sell immediately? Or is it worth buying Palantir?
On the product front, Palantir unveiled “AIP Evolve” in late August, a beta feature designed to coordinate fleets of AI agents that optimize systems autonomously. The company also expanded its Foundry offering with role-based compute profiles — a technical but meaningful enhancement for enterprise clients concerned about access control.
The Insider Overhang
Yet the counter-narrative persists. CEO Alexander Karp filed paperwork under Rule 144 on August 25 signaling his intention to sell up to 90,000 shares worth roughly $15.8 million — a planned but not yet executed transaction. Just days earlier, on August 20, Karp had already disposed of 492,348 Class A shares under an existing Rule 10b5-1 plan, generating approximately $86.06 million to cover tax obligations tied to vesting restricted stock units. Director Alexander D. Moore sold 16,000 shares on August 17 under a similar arrangement, and Chief Accounting Officer Jeffrey Buckley also trimmed his position during the month.
These transactions run through automated, pre-arranged trading plans — a technical detail that tempers any sense of panic. But the sheer frequency of insider filings, in a stock that has already run hard, remains difficult to ignore.
The valuation question has drawn at least one prominent skeptic. Seeking Alpha contributor Juxtaposed Ideas downgraded Palantir from “Buy” to “Hold” on August 18, citing stretched multiples following the post-earnings rally and the persistent insider selling. That call is now more than four weeks old, but it shows the valuation debate was already simmering in August, well before it became a broader talking point.
Politics and Positioning
Palantir’s political calculus has also drawn attention. Reports suggest the company is shifting more of its political contributions toward Democrats ahead of the midterm elections, including larger campaign donations. That reads as hedging against regulatory risk should control of the House change hands — a signal that even Palantir doesn’t assume frictionless continuity in its government business.
For investors, the picture is not simple. The company is growing faster than expected, the defense segment benefits from a structural shift in how military budgets allocate spending toward software and data platforms, and the stock has visibly detached from its medium-term base. With an annualized 30-day volatility of 100 percent, this remains a holding for those with strong stomachs. The coming weeks will show whether the growth narrative can outrun the steady drip of insider sales — and whether the valuation debate, once raised, can be put back to rest.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from August 31 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 31.
Palantir: Buy or sell? Read more here...
